object
provid
cuttingedg
inform
manag
communityacquir
pneumonia
children
year
base
latest
evid
publish
literatur
data
sourc
comprehens
search
conduct
pubm
use
expressionsal
articl
retriev
titl
abstract
read
paper
report
latest
evid
subject
identifi
download
complet
read
data
synthesi
era
larg
implement
bacteri
conjug
vaccin
widespread
use
amplif
nucleic
acid
techniqu
respiratori
virus
identifi
frequent
caus
agent
communityacquir
pneumonia
patient
year
hypoxemia
oxygen
satur
increas
work
breath
sign
associ
communityacquir
pneumonia
wheez
detect
physic
examin
independ
predict
viral
infect
neg
predict
valu
confid
interv
normal
chest
xray
serum
procalcitonin
ngdl
respect
inabl
drinkfe
vomit
everyth
convuls
lower
chest
indraw
central
cyanosi
lethargi
nasal
flare
grunt
head
nod
oxygen
satur
predictor
death
use
indic
hospit
moderatelarg
pleural
effus
multilobar
infiltr
predictor
sever
diseas
oral
administ
amoxicillin
first
line
outpati
treatment
ampicillin
aqueou
penicillin
g
amoxicillin
initi
initi
intraven
rout
first
line
option
treat
inpati
conclus
distinct
aspect
childhood
communityacquir
pneumonia
chang
last
three
decad
communityacquir
pneumonia
cap
still
lead
caus
death
among
children
age
less
year
worldwid
estim
million
death
inde
cap
second
preterm
birth
complic
lead
caus
death
countri
high
mortal
rate
yet
import
medium
high
medium
child
mortal
countri
furthermor
cap
impos
substanti
burden
health
servic
major
caus
hospit
referr
admiss
accord
last
estim
roughli
death
due
cap
took
place
hospit
develop
countri
therefor
possibl
observ
death
happen
outsid
hospit
particularli
subsaharan
africa
southern
asia
countri
brazil
hospit
admiss
occur
among
children
year
frequent
caus
admiss
respiratori
diseas
perinat
complic
infectiousparasit
ill
regard
mortal
death
due
respiratori
diseas
regist
age
rang
brazil
ie
case
hospit
die
case
fatal
rate
figur
agreement
find
mortal
morbid
accord
econom
develop
countri
brazil
upper
middl
incom
countri
although
cap
frequent
caus
death
major
caus
hospit
admiss
brazil
due
impact
childhood
morbid
mortal
health
care
assist
paramount
updat
diagnos
treat
children
cap
thu
studi
aim
provid
cuttingedg
inform
manag
cap
patient
year
base
latest
evid
publish
literatur
bacteri
infect
main
concern
cap
etiolog
particularli
pneumococc
infect
besid
classic
concept
medicin
deriv
avail
bacteriolog
assay
routin
use
investig
cap
etiolog
concept
highlight
find
death
due
cap
mainli
secondari
bacteri
infect
base
find
world
health
organ
launch
program
guidelin
aim
identifi
children
risk
cap
receiv
empir
antibiot
treatment
promptli
matter
fact
program
quickli
deem
substanti
effect
child
mortal
end
last
centuri
begin
current
one
signific
chang
occur
childhood
cap
scenario
firstli
progress
implement
bacteri
conjug
vaccin
specif
haemophilu
influenza
type
b
hib
vaccin
pneumococc
conjug
vaccin
pcv
frequent
bacteri
caus
agent
cap
among
children
far
recogn
widespread
use
hib
vaccin
pcv
countri
high
child
mortal
associ
reduct
hib
pneumococc
case
death
secondli
success
widespread
use
amplif
nucleic
acid
techniqu
pcr
impact
estim
proport
respiratori
viru
infect
childhood
cap
american
studi
conduct
children
hospit
due
cap
respiratori
virus
detect
virus
detect
swedish
studi
conduct
pediatr
emerg
room
inpati
ward
case
radiograph
evid
cap
healthi
control
enrol
respect
virus
found
author
report
influenza
human
metapneumoviru
hmpv
respiratori
syncyti
viru
rsv
detect
case
significantli
associ
cap
odd
ratio
australian
studi
carri
children
hospit
cap
healthi
control
respiratori
virus
particularli
rsv
hmpv
major
contributor
cap
etiolog
author
estim
rsv
hmpv
influenza
adenoviru
mycoplasma
pneumonia
respons
ci
hospit
respect
turn
multicent
studi
conduct
eight
develop
countri
cambodia
china
haiti
india
madagascar
mali
mongolia
paraguay
gabriel
studi
case
hospit
radiolog
confirm
cap
healthi
control
recruit
least
one
microorgan
detect
case
control
streptococcu
pneumonia
pneumonia
hmpv
rhinoviru
rsv
parainfluenza
viru
influenza
viru
b
independ
associ
pneumonia
author
specul
increas
pneumonia
vaccin
coverag
may
substanti
reduc
burden
cap
among
children
develop
countri
brazil
two
distinct
studi
thoroughli
investig
cap
etiolog
first
one
hospit
case
radiologicallyconfirm
cap
includ
viral
bacteri
viralbacteri
infect
found
patient
respect
rhinoviru
pneumonia
common
pathogen
parainfluenza
virus
rsv
influenza
b
human
bocaviru
hbov
enteroviru
hmpv
adenoviru
infect
diagnos
second
studi
nonhospit
case
recruit
virus
detect
multipl
virus
rhinoviru
adenoviru
enteroviru
rsv
parainfluenza
viru
hmpv
influenza
b
coronaviru
found
studi
virus
significantli
frequent
among
case
multipl
detect
except
rsv
influenza
virus
furthermor
acut
hbov
infect
serolog
confirm
case
avail
pair
serum
sampl
typic
bacteri
infect
also
search
employ
quantit
specif
igg
titer
patient
pair
serum
sampl
avail
assay
rate
antibodi
respons
least
one
pneumococc
protein
antigen
h
influenza
catarrhali
detect
rate
signific
antibodi
increas
least
one
three
bacteria
atyp
bacteri
infect
also
investig
pneumonia
acut
infect
diagnos
detect
specif
igm
antibodi
convalesc
serum
sampl
chlamydia
pneumonia
chlamydia
trachomati
acut
infect
diagnos
detect
specif
igm
antibodi
signific
igg
iga
titer
chang
overal
pneumonia
c
pneumonia
c
trachomati
acut
infect
diagnos
patient
investig
three
bacteria
acut
infect
least
one
three
bacteria
patient
concomitantli
posit
test
acut
pneumonia
acut
c
pneumonia
infect
base
aforement
data
possibl
observ
respiratori
virus
increasingli
implic
childhood
cap
etiolog
along
recognit
viral
infect
frequent
bacteri
infect
even
develop
countri
screen
children
complaint
acut
respiratori
infect
diagnos
pneumonia
reli
initi
clinic
aspect
sinc
earli
recommend
use
quantit
tachypnea
agespecif
elev
respiratori
rate
identifi
children
would
requir
treatment
antibiot
possibl
pneumonia
necessari
clarifi
respiratori
rate
criteria
select
base
field
observ
studi
target
epidemiolog
set
due
high
sensit
reason
specif
eas
implement
access
formal
medic
evalu
limit
addit
evid
base
establish
criteria
prior
introduct
vaccin
hib
pneumonia
regard
two
major
caus
cap
mortal
also
necessari
emphas
respiratori
rate
criteria
diagnost
approach
instead
recommend
employ
easi
tool
identifi
among
children
year
acut
respiratori
infect
complaint
chanc
compromis
lower
respiratori
tract
could
risk
die
recent
publish
systemat
review
accuraci
symptom
physic
examin
find
identifi
case
radiograph
pneumonia
among
children
younger
year
prospect
cohort
studi
children
includ
eight
north
america
among
preval
radiograph
pneumonia
north
american
studi
outsid
north
america
presenc
moder
hypoxemia
oxygen
satur
increas
work
breath
grunt
flare
retract
sign
associ
pneumonia
wherea
normal
oxygen
oxygen
satur
decreas
likelihood
pneumonia
curious
tachypnea
respiratori
rate
breathsmin
strongli
associ
pneumonia
diagnosi
inde
limit
respiratori
ratebas
pneumonia
diagnosi
also
includ
overdiagnosi
due
inclus
case
asthma
respiratori
ailment
compromis
lower
respiratori
tract
studi
conduct
three
rural
hospit
rwanda
may
april
case
analyz
radiologistdiagnos
pneumonia
accuraci
diagnos
radiologicallyconfirm
pneumonia
assess
histor
clinic
laboratori
sign
oxygen
satur
best
clinic
predictor
area
receiv
oper
characterist
roc
curv
ci
p
higher
respiratori
rate
ci
p
malawi
children
age
month
clinicallydiagnos
pneumonia
evalu
author
demonstr
oximetri
increas
referr
rate
sever
hypoxem
children
without
chest
indraw
danger
sign
inde
oximetri
data
exclud
retrospect
applic
guidelin
publish
fail
identifi
consider
proport
sever
hypoxem
children
elig
via
oximetri
furthermor
shown
puls
oximetri
significantli
increas
incid
correctli
treat
sever
case
also
reduc
incid
incorrect
treatment
antibiot
gold
standard
usual
consid
investig
predict
sign
pneumonia
radiologicallyconfirm
pneumonia
radiolog
find
consist
pneumonia
includ
pulmonari
infiltr
either
alveolar
interstiti
alveolar
infiltr
character
dens
fluffi
opac
occupi
portion
entir
lobe
even
entir
lung
may
may
contain
airbronchogram
interstiti
infiltr
defin
linear
patchi
densiti
laci
pattern
interestingli
demonstr
sensit
ci
radiologicallyconfirm
pneumonia
pneumococc
infect
convers
neg
predict
valu
ci
normal
chest
xray
find
detect
among
hospit
nonhospit
children
thu
find
radiologicallyconfirm
pneumonia
actual
predictor
bacteri
pneumonia
moreov
frequenc
bacteri
pneumonia
decreas
due
wide
implement
conjug
vaccin
hib
pcv
accuraci
predictor
may
chang
time
among
differ
set
depend
vaccin
coverag
practic
standpoint
bacteri
pneumonia
target
children
typic
bacteri
infect
alon
complic
viral
infect
wors
outcom
infect
viru
alon
prospect
crosssect
studi
investig
cap
etiolog
virus
eight
bacteria
hospit
children
year
frequenc
sign
symptom
assess
patient
viral
exclus
bacteri
infect
patient
probabl
etiolog
establish
viral
mix
viralbacteri
bacteri
infect
asthma
observ
multivari
analysi
viral
infect
adjor
ci
ci
asthma
adjor
ci
ci
age
adjor
ci
ci
independ
associ
wheez
physic
examin
posit
predict
valu
detect
wheez
viral
infect
ci
author
conclud
wheez
detect
physic
examin
independ
predictor
viral
infect
howev
wheez
rule
bacteri
infect
practic
necessari
identifi
children
cap
mainli
probabl
bacteri
infect
possibl
combin
normal
chest
xray
detect
wheez
upon
physic
examin
puls
oximetri
may
use
goal
potenti
issu
futur
research
use
blood
inflammatori
biomark
distinguish
bacteri
viral
cap
investig
procalcitonin
pct
creactiv
protein
crp
shown
valu
identif
bacteri
infect
establish
yet
relev
clinic
cutoff
point
use
instanc
italian
random
clinic
trial
children
nonsever
cap
admit
hospit
specif
includ
pct
investig
receiv
antibiot
mean
serum
pct
upon
admiss
ngml
remain
children
receiv
antibiot
base
clinic
evalu
attend
physician
antibiot
prescrib
children
first
group
children
second
group
p
length
antibiot
use
lower
vs
p
well
frequenc
advers
event
relat
antibiot
use
vs
p
group
serum
pct
measur
necessari
emphas
none
patient
receiv
antibiot
worsen
need
antibiot
afterward
brazilian
studi
describ
serum
pct
upon
admiss
ngdl
high
neg
predict
valu
pneumococc
infect
import
highlight
studi
patient
radiologicallyconfirm
pneumonia
reason
even
chest
radiograph
confirm
cap
diagnost
appear
possibl
identifi
children
benefit
antibiot
use
exampl
consid
serum
pct
level
ngml
addit
independ
associ
pneumococc
infect
high
neg
predict
valu
among
children
year
age
hospit
cap
date
lack
inform
nonhospit
children
age
rang
moreov
combin
biomark
tumor
necrosi
factorrel
apoptosisinduc
ligand
creactiv
protein
interferon
induc
protein
describ
use
distinguish
bacteri
viral
infect
hospit
children
howev
less
children
investig
common
pitfal
kind
studi
children
without
bacteri
cap
identifi
exampl
recent
publish
studi
australia
definit
bacteri
infect
describ
clinic
empyema
andor
bacteria
detect
blood
pleural
effus
presum
viral
pneumonia
compris
least
one
viru
detect
nasopharyng
swab
without
criteria
definit
bacteri
pneumonia
fact
use
definit
author
group
case
two
subgroup
first
invas
bacteri
infect
second
without
invas
bacteri
infect
possibl
viral
infect
great
challeng
group
cap
case
bacteri
infect
diagnosi
noninvas
bacteri
infect
method
employ
diagnos
noninvas
bacteri
infect
patient
mislabel
case
without
bacteri
infect
undoubtedli
identif
valid
tool
reliabl
distinguish
among
children
cap
viral
infect
bacteri
infect
prioriti
childhood
cap
research
field
clinic
manag
requir
assess
defin
whether
patient
requir
hospit
review
seven
distinct
childhood
cap
countri
repres
guidelin
possibl
observ
criteria
recommend
hospit
admiss
differ
develop
develop
countri
unit
state
canada
unit
kingdom
japan
sign
respiratori
distress
includ
tachypnea
indic
hospit
wherea
brazil
south
africa
guidelin
tachypnea
alon
regard
indic
start
antibiot
ambulatori
basi
made
consider
chang
guidelin
patient
tachypnea
chest
indraw
formal
recommend
hospit
indic
oral
antibiot
outpati
treatment
onward
figur
develop
countri
prior
introduct
pcv
estim
approxim
million
episod
cap
includ
million
children
hospit
ill
annual
among
children
age
year
contrast
estim
develop
countri
million
new
episod
annual
associ
hospit
possibl
observ
proport
cap
case
associ
hospit
greater
children
develop
compar
develop
countri
differ
proport
cap
case
hospit
develop
develop
countri
like
reflect
combin
physician
differ
manag
limit
access
health
care
differ
healthcar
seek
behavior
among
parent
children
rather
less
sever
diseas
among
children
develop
countri
furthermor
health
care
system
structur
differ
develop
develop
countri
realiti
publish
studi
develop
countri
systemat
compar
outcom
children
treat
outpati
hospit
children
accord
vari
degre
respiratori
distress
current
recommend
develop
countri
base
assumpt
children
reason
access
healthcar
includ
evalu
doctor
attend
physician
overal
assess
child
clinic
statu
anticip
clinic
cours
use
determin
whether
hospit
requir
data
four
develop
countri
particip
gabriel
studi
show
case
age
month
hospit
radiologicallyconfirm
pneumonia
die
hypoxemia
pneumonia
detect
blood
pcr
predictor
death
lower
chest
indraw
along
cyanosi
predict
hypoxemia
moreov
hmpv
rsv
independ
associ
increas
risk
hypoxemia
furthermor
data
children
month
old
hospit
sever
sever
pneumonia
includ
perch
studi
conduct
seven
lowand
middleincom
countri
demonstr
age
year
femal
sex
day
ill
prior
present
hospit
low
weightforheight
unrespons
deep
breath
hypoxemia
grunt
absenc
cough
predictor
death
author
also
point
chanc
die
increas
accord
number
danger
sign
present
danger
sign
one
danger
sign
danger
sign
besid
number
danger
sign
present
hospit
c
accur
stratum
score
c
respiratori
index
sever
children
c
danger
sign
includ
central
cyanosi
oxygen
satur
puls
oximetri
inabl
drinkfe
vomit
everyth
convuls
lethargi
impair
conscious
sever
respiratori
distress
sever
respiratori
distress
defin
nasal
flare
grunt
head
nod
use
auxiliari
muscl
breath
presenc
labor
fast
gasp
breath
child
unabl
feed
respiratori
distress
tire
easili
inabl
drinkfe
vomit
convuls
lower
chest
indraw
central
cyanosi
lethargi
nasal
flare
grunt
head
nod
recogn
reliabl
easili
detect
predictor
death
among
hospit
children
cap
well
oxygen
satur
hypoxemia
despit
fact
find
base
case
treat
hospit
therefor
possibl
infer
case
may
success
manag
home
possibl
recogn
evidencebas
predictor
therefor
use
clinic
manag
cap
case
across
divers
set
particularli
aid
decis
patient
hospit
treatment
anoth
studi
conduct
four
hospit
unit
state
recruit
children
year
old
hospit
clinic
radiograph
evid
pneumonia
aim
assess
whether
radiograph
find
predict
outcom
admiss
radiograph
categor
singl
lobar
unilater
bilater
multilobar
interstiti
pulmonari
infiltr
well
absent
small
moderatelarg
pleural
effus
author
report
find
moderatelarg
pleural
effus
bilater
multilobar
infiltr
present
strongest
associ
sever
diseas
multilobar
either
unilater
bilater
interstiti
infiltr
associ
need
intens
care
thu
chest
xray
valuabl
tool
contribut
improv
qualiti
care
may
help
predict
diseas
sever
gener
agreement
among
distinct
intern
guidelin
oral
administ
amoxicillin
first
line
option
treat
outpati
ampicillin
aqueou
penicillin
g
amoxicillin
initi
initi
intraven
rout
first
line
option
treat
inpati
cap
year
group
agreement
base
gener
consensu
pneumonia
common
dread
bacteri
caus
agent
childhood
cap
among
children
year
therefor
target
antibiot
therapi
exampl
pneumonia
detect
blood
pcr
recent
identifi
predictor
hypoxemia
among
children
hospit
cap
systemat
review
publish
analyz
random
clinic
trial
publish
april
children
cap
treat
antibiot
follow
studi
includ
evalu
efficaci
amoxicillin
nonsever
nonhospit
patient
eight
evalu
efficaci
amoxicillin
hospit
patient
thu
amoxicillin
studi
antimicrobi
best
methodolog
approach
reliabl
evid
two
differ
dose
regimen
compar
clinic
trial
conduct
salvador
brazil
children
nonsever
cap
randomli
assign
receiv
mgkgday
amoxicillin
either
twice
thrice
day
placebocontrol
random
tripleblind
clinic
trial
show
equival
efficaci
regimen
thu
comfort
conveni
dosag
mgkgday
twice
daili
use
base
scienc
evid
import
recal
key
pharmacodynam
paramet
amoxicillin
efficaci
length
time
minim
inhibitori
concentr
mic
dose
interv
treatment
pneumococc
cap
pharmacokinet
studi
compar
twice
thrice
daili
dose
children
receiv
mgkgday
report
patient
amoxicillin
concentr
ugml
dose
interv
amoxicillin
concentr
ugl
dose
interv
twicedaili
dose
arm
indic
appropri
mgkgday
dose
amoxicillin
need
reevalu
accord
mic
pneumococc
strain
isol
region
instanc
canadian
author
recent
advis
routin
use
higher
dose
amoxicillin
treat
nonsever
cap
case
canada
pneumococc
strain
present
intermedi
resist
mic
ugml
amoxicillin
author
also
argu
unjustifi
use
higher
dose
amoxicillin
lead
increas
cost
side
effect
total
antibiot
exposur
harm
effect
patient
microbiom
also
consid
common
practic
question
whether
macrolid
given
empir
firstlin
option
treat
children
cap
sever
attempt
made
address
question
far
strongest
evid
provid
brazilian
studi
children
year
nonsever
cap
given
amoxicillin
prospect
followedup
amoxicillin
substitut
children
diagnos
acut
infect
pneumonia
c
pneumonia
children
without
kind
infect
p
three
children
acut
infect
c
trachomati
present
therapeut
failur
amoxicillin
antibiot
use
entir
treatment
period
author
conclud
necessari
treat
atyp
bacteri
infect
everi
child
age
month
nonsever
cap
contrari
macrolid
use
could
reserv
rare
case
amoxicillin
effect
practic
question
regard
length
antibiot
therapi
systemat
review
publish
evalu
efficaci
short
long
cours
antibiot
children
age
month
nonsever
cap
identifi
two
clinic
trial
three
five
day
amoxicillin
use
compar
one
india
anoth
pakistan
one
clinic
trial
three
five
day
cotrimoxazol
compar
indonesia
bangladesh
neither
studi
indic
differ
efficaci
per
treatment
length
utmost
import
notic
three
studi
diagnos
cap
patient
accord
diagnost
criteria
presenc
tachypnea
evid
case
asthma
bronchiol
lower
respiratori
tract
diseas
includ
cap
diagnost
erron
made
children
respiratori
morbid
result
studi
diagnos
cap
use
criteria
gener
case
diagnos
clinic
practic
criteria
result
might
differ
radiologicallyconfirm
pneumonia
bacteri
pneumonia
context
author
highlight
isra
clinic
trial
publish
children
age
month
radiolog
find
alveolar
infiltr
chest
radiograph
taken
upon
admiss
temperatur
c
leucocyt
total
count
mm
without
danger
sign
followedup
daili
author
first
compar
three
day
treatment
ten
day
due
rate
therapeut
failur
first
arm
none
second
arm
preliminari
interim
analysi
switch
durat
treatment
first
arm
five
day
end
case
treat
either
five
ten
day
amoxicillin
respect
without
therapeut
failur
author
conclud
five
day
amoxicillin
enough
treat
cap
alveolar
infiltr
without
danger
sign
complic
remark
significantli
alter
recommend
children
fast
breath
wheez
chest
indraw
danger
sign
fever
c
antibiot
routin
recommend
caus
like
viral
infect
ruptur
old
polici
prescrib
antibiot
children
younger
year
old
cough
tachypnea
risk
bacteri
infect
death
due
recognit
respiratori
virus
major
caus
cap
children
well
simpl
clinic
sign
fever
wheez
may
preliminarili
screen
children
prone
bacteri
infect
note
advis
antibiot
therapi
hospit
patient
ampicillin
aqueou
penicillin
g
amoxicillin
initi
initi
intraven
rout
first
line
option
american
guidelin
state
third
gener
cephalosporin
could
first
choic
place
high
preval
pneumococc
resist
penicillin
mic
ugml
alreadi
demonstr
patient
infect
pneumococc
strain
mic
ugml
present
good
respons
treat
aqueou
penicillin
g
dosag
uikgday
also
shown
daili
dosag
uikgday
efficaci
given
everi
h
everi
h
treatment
manag
larger
interv
dose
comfort
patient
healthcar
profession
enhanc
adher
besid
cheaper
healthcar
institut
also
relev
comment
hospit
patient
cap
evolv
antibiot
treatment
anoth
brazilian
studi
includ
hospit
children
older
month
age
radiologicallyconfirm
cap
treat
aqueou
penicillin
g
uikgday
penicillin
substitut
case
due
deterior
clinic
statu
among
remain
case
receiv
aqueou
penicillin
g
throughout
treatment
period
tachypnea
fever
chest
indraw
still
present
h
antibiot
therapi
case
respect
symptom
present
h
treatment
onset
case
respect
notabl
patient
present
full
recoveri
discharg
hospit
oral
amoxicillin
replac
aqueou
penicillin
g
home
complet
antimicrobi
therapi
number
show
patient
may
slow
recoveri
suggest
need
antibiot
replac
patient
present
clinicalradiolog
deterior
therefor
use
ceftriaxon
case
sever
diseas
associ
oxacillin
macrolid
occur
specif
situat
possibl
assum
presenc
high
penicillin
resist
pneumococcu
produc
h
influenza
ceftriaxon
indic
staphylococcu
aureu
oxacillin
indic
even
atyp
bacteria
macrolid
indic
patient
month
age
hospit
receiv
intraven
antibiot
higher
chanc
die
cap
regardless
factor
compar
children
older
month
age
stratum
group
b
streptococcu
gramneg
intestin
bacteria
listeria
monocytogen
pneumonia
potenti
caus
agent
antibiot
therapi
age
group
includ
administr
either
intraven
iv
intramuscular
im
ampicillin
associ
amynoglycosid
throughout
whole
treatment
upward
possibl
substitut
amynoglycosid
thirdgener
cephalosporin
age
month
cefotaxim
first
choic
drug
consid
hyperbilirubinemia
prematur
ceftriaxon
increas
risk
kernicteru
patient
high
avid
serum
protein
especi
albumin
bond
bilirubin
c
trachomati
suspect
presenc
conjunct
case
recommend
antibiot
choic
erythromycin
comment
corticosteroid
adjunct
therapi
made
spanish
studi
perform
multicent
random
doubleblind
parallelgroup
placebocontrol
clinic
trial
sixti
children
age
month
year
cap
pleural
effus
includ
author
describ
faster
recoveri
rate
measur
object
hour
group
receiv
dexamethason
dxm
mgkg
everi
h
h
plu
cefotaxim
compar
control
group
signific
differ
advers
event
attribut
studi
drug
except
hyperglycemia
therefor
author
conclud
dxm
appear
safe
effect
adjunct
therapi
decreas
time
recoveri
children
parapneumon
pleural
effus
anoth
studi
includ
children
sever
cap
patient
receiv
methylprednisolon
cours
plu
imipenem
patient
receiv
imipenem
plu
placebo
author
report
methylprednisolon
group
faster
resolut
symptom
recent
systemat
review
identifi
four
random
control
trial
includ
children
corticosteroid
reduc
earli
clinic
failur
rate
rr
ci
highqual
evid
base
two
small
clinic
heterogen
trial
reduc
time
clinic
cure
date
role
corticosteroid
adjunct
chemic
therapi
childhood
cap
yet
establish
support
need
recommend
use
corticosteroid
clinic
practic
across
distinct
sever
subgroup
associ
differ
antibiot
especi
cap
still
major
caus
morbid
mortal
among
children
age
year
worldwid
current
respiratori
virus
recogn
major
caus
agent
hypoxemia
oxygen
satur
increas
work
breath
associ
sign
cap
regard
sever
assess
danger
sign
inabl
drinkfe
vomit
everyth
convuls
lower
chest
indraw
central
cyanosi
lethargi
nasal
flare
grunt
head
nod
oxygen
satur
recogn
predictor
death
use
indic
hospit
first
line
option
antibiot
treatment
compris
oral
amoxicillin
outpati
ampicillin
aqueou
penicillin
g
amoxicillin
initi
initi
intraven
rout
inpati
futur
investig
priorit
identif
valid
tool
distinguish
among
children
cap
viral
infect
bacteri
infect
cmnc
senior
investig
brazilian
council
scientif
technolog
develop
cnpq
